These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27137421)

  • 1. Guideline adherence for mentally ill reproductive-aged women on treatment with valproic acid: a retrospective chart review.
    Gotlib D; Perelstein E; Kurlander J; Zivin K; Riba M; Muzik M
    J Clin Psychiatry; 2016 Apr; 77(4):527-34. PubMed ID: 27137421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should women of childbearing potential be prescribed valproate? a call to action.
    Balon R; Riba M
    J Clin Psychiatry; 2016 Apr; 77(4):525-6. PubMed ID: 27137420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate.
    Craig J; Morrison P; Morrow J; Patterson V
    Seizure; 1999 Jun; 8(4):253-4. PubMed ID: 10452927
    [No Abstract]   [Full Text] [Related]  

  • 4. Brief report novel mechanism for valproate-induced teratogenicity.
    Fathe K; Palacios A; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2014 Aug; 100(8):592-7. PubMed ID: 25066307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic Acid in Women and Girls of Childbearing Age.
    Gotlib D; Ramaswamy R; Kurlander JE; DeRiggi A; Riba M
    Curr Psychiatry Rep; 2017 Sep; 19(9):58. PubMed ID: 28726062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats].
    Ubeda-Martín N; Alonso-Aperte E; Achón M; Varela-Moreiras G; Puerta J; Pérez de Miguelsanz J
    Nutr Hosp; 1998; 13(1):41-9. PubMed ID: 9578686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
    Padmanabhan R; Shafiullah MM
    Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogenicity of sodium valproate.
    Alsdorf R; Wyszynski DF
    Expert Opin Drug Saf; 2005 Mar; 4(2):345-53. PubMed ID: 15794725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study.
    Bosak M; Słowik A; Turaj W
    Epilepsy Behav; 2019 Sep; 98(Pt A):1-5. PubMed ID: 31299525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation.
    Yerby MS
    Epilepsia; 2003; 44 Suppl 3():33-40. PubMed ID: 12790884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
    Nau H; Hauck RS; Ehlers K
    Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.
    Wilson RD; ; Wilson RD; Audibert F; Brock JA; Carroll J; Cartier L; Gagnon A; Johnson JA; Langlois S; Murphy-Kaulbeck L; Okun N; Pastuck M; ; Deb-Rinker P; Dodds L; Leon JA; Lowel HL; Luo W; MacFarlane A; McMillan R; Moore A; Mundle W; O'Connor D; Ray J; Van den Hof M
    J Obstet Gynaecol Can; 2015 Jun; 37(6):534-52. PubMed ID: 26334606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate and folate: Congenital and developmental risks.
    Reynolds EH; Green R
    Epilepsy Behav; 2020 Jul; 108():107068. PubMed ID: 32375098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
    Jentink J; Bakker MK; Nijenhuis CM; Wilffert B; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):803-7. PubMed ID: 20680999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate increases valproic acid-induced developmental toxicity, in particular neural tube defects in mice.
    Elmazar MM; Nau H
    Teratog Carcinog Mutagen; 1992; 12(5):203-10. PubMed ID: 1363493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pregnancy, contraception and epilepsy].
    Leppert D; Wieser HG
    Nervenarzt; 1993 Aug; 64(8):494-503. PubMed ID: 8413747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature.
    Kozma C
    Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency.
    Roy M; Leclerc D; Wu Q; Gupta S; Kruger WD; Rozen R
    J Cell Biochem; 2008 Oct; 105(2):467-76. PubMed ID: 18615588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis.
    Wegner C; Nau H
    Neurology; 1992 Apr; 42(4 Suppl 5):17-24. PubMed ID: 1574172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.